Healthcare provider profile · identity verified

Joanna S Cichon, MD

Internal Medicine · CHICOPEE, MA · NPI 1891768529

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	614	181
Amlodipine Besylate	Amlodipine Besylate	575	151
Lisinopril	Lisinopril	420	116
Levothyroxine Sodium	Levothyroxine Sodium	418	105
Metoprolol Succinate	Metoprolol Succinate	388	109
Omeprazole	Omeprazole	371	108
Rosuvastatin Calcium	Rosuvastatin Calcium	321	90
Pravastatin Sodium	Pravastatin Sodium	295	83
Sertraline Hcl	Sertraline Hcl	233	80
Simvastatin	Simvastatin	227	62
Gabapentin	Gabapentin	226	57
Furosemide	Furosemide	222	70
Olmesartan Medoxomil	Olmesartan Medoxomil	219	58
Eliquis	Apixaban	218	59
Metformin Hcl	Metformin Hcl	209	59
Losartan Potassium	Losartan Potassium	192	50
Hydrochlorothiazide	Hydrochlorothiazide	173	51
Albuterol Sulfate Hfa	Albuterol Sulfate	143	51
Metformin Hcl Er	Metformin Hcl	129	38
Metoprolol Tartrate	Metoprolol Tartrate	121	34
Pantoprazole Sodium	Pantoprazole Sodium	116	33
Famotidine	Famotidine	103	28
Montelukast Sodium	Montelukast Sodium	97	31
Ozempic	Semaglutide	94	27
Alendronate Sodium	Alendronate Sodium	90	25
Donepezil Hcl	Donepezil Hcl	90	18
Atenolol	Atenolol	89	28
Trazodone Hcl	Trazodone Hcl	86	26
Farxiga	Dapagliflozin Propanediol	83	25
Breo Ellipta	Fluticasone/Vilanterol	82	21
Irbesartan	Irbesartan	82	21
Carvedilol	Carvedilol	80	23
Tamsulosin Hcl	Tamsulosin Hcl	80	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	80	19
Potassium Chloride	Potassium Chloride	79	22
Citalopram Hbr	Citalopram Hydrobromide	78	24
Meloxicam	Meloxicam	78	30
Trulicity	Dulaglutide	72	24
Valsartan	Valsartan	71	19
Fluticasone Propionate	Fluticasone Propionate	69	24
Spironolactone	Spironolactone	69	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	18
Allopurinol	Allopurinol	66	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	21
Ezetimibe	Ezetimibe	62	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	13
Ropinirole Hcl	Ropinirole Hcl	55	13
Ibuprofen	Ibuprofen	54	suppressed
Jardiance	Empagliflozin	54	14
Hydralazine Hcl	Hydralazine Hcl	53	16
Buspirone Hcl	Buspirone Hcl	51	16
Estradiol	Estradiol	51	30
Prednisone	Prednisone	51	37
Synthroid	Levothyroxine Sodium	50	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	46	12
Fluoxetine Hcl	Fluoxetine Hcl	45	17
Mirtazapine	Mirtazapine	45	11
Escitalopram Oxalate	Escitalopram Oxalate	44	14
Glipizide	Glipizide	44	14
Finasteride	Finasteride	43	14
Lorazepam	Lorazepam	43	22
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	32
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	39	11
Mounjaro	Tirzepatide	39	11
Triamcinolone Acetonide	Triamcinolone Acetonide	36	22
Lovastatin	Lovastatin	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Azithromycin	Azithromycin	31	28
Baclofen	Baclofen	31	19
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	31	suppressed
Amoxicillin	Amoxicillin	29	16
Bupropion Xl	Bupropion Hcl	29	suppressed
Celecoxib	Celecoxib	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Ketoconazole	Ketoconazole	25	18
Pregabalin	Pregabalin	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	22	suppressed
Hydrocortisone	Hydrocortisone	22	12
Doxycycline Hyclate	Doxycycline Hyclate	21	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Nystatin	Nystatin	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Myrbetriq	Mirabegron	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Digoxin	Digoxin	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Levoxyl	Levothyroxine Sodium	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Indapamide	Indapamide	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Prolia	Denosumab	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error